The Number of Fetal Nephron Progenitor Cells Limits Ureteric Branching and Adult Nephron Endowment  by Cebrian, Cristina et al.
Cell Reports
ArticleThe Number of Fetal Nephron Progenitor Cells
Limits Ureteric Branching
and Adult Nephron Endowment
Cristina Cebrian,1 Naoya Asai,1,3 Vivette D’Agati,2 and Frank Costantini1,*
1Department of Genetics and Development, Columbia University, New York, NY 10032, USA
2Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA
3Present address: Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan
*Correspondence: fdc3@columbia.edu
http://dx.doi.org/10.1016/j.celrep.2014.02.033
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARY
Nephrons, the functional units of the kidney, develop
from progenitor cells (cap mesenchyme [CM]) sur-
rounding the epithelial ureteric bud (UB) tips.
Reciprocal signaling between UB and CM induces
nephrogenesis and UB branching. Although low
nephron number is implicated in hypertension and
renal disease, the mechanisms that determine
nephron number are obscure. To test the importance
of nephron progenitor cell number, we genetically
ablated 40% of these cells, asking whether this
would limit kidney size and nephron number or
whether compensatory mechanisms would allow
the developing organ to recover. The reduction in
CM cell number decreased the rate of branching,
which in turn allowed the number of CM cells per
UB tip to normalize, revealing a self-correctionmech-
anism. However, the retardedUBbranching impaired
kidney growth, leaving a permanent nephron deficit.
Thus, the number of fetal nephron progenitor cells is
an important determinant of nephron endowment,
largely via its effect on UB branching.INTRODUCTION
The mammalian kidney is a complex organ that is essential for
the removal of waste products and the homeostasis of body
fluids and electrolytes. The kidneys arise through reciprocal
and sequential interactions between two tissues derived from
intermediate mesoderm: the ureteric bud (UB), an epithelial
outgrowth of the nephric duct, and the neighboring metanephric
mesenchyme (MM) (Saxe´n, 1987). Signals from the MM induce
the formation and subsequent growth and branching of the
UB, generating the entire renal collecting duct system. Simulta-
neously, signals from the UB induce the condensation, epitheli-
alization, and differentiation of multipotential progenitor cells in
the MM into nephrons, the filtering units of the kidney (reviewed
in Costantini and Kopan, 2010; Little and McMahon, 2012).In humans, the number of nephrons per kidney varies greatly
(10-fold) among individuals, and low nephron number has sig-
nificant clinical implications, as it has been associated with hy-
pertension, proteinuria, and chronic kidney disease (Bertram
et al., 2011; Hoy et al., 2006; Keller et al., 2003; Luyckx and Bren-
ner, 2005; Schreuder, 2012). In the adult mammalian kidney, the
renal tubular network and multiple glomerular structures un-
dergo constant cell renewal as a consequence of aging and
injury (Humphreys et al., 2008; Vogetseder et al., 2005), but there
is no evidence for the generation of new nephrons. As a conse-
quence, the nephron endowment is limited to the number of
nephrons that formed during renal organogenesis. Hence, it is
important to understand the developmental mechanisms that
determine nephron number.
Most components of the nephron, including the glomerulus,
proximal tubule, loop of Henle, distal tubule, and connecting
tubule, derive from a population of multipotent, self-renewing
progenitor cells (Boyle et al., 2008; Kobayashi et al., 2008; Little
and McMahon, 2012; Mugford et al., 2008), whereas the mesan-
gial and endothelial cells of the glomerulus arise from different
progenitor cells (Humphreys et al., 2010; Little and McMahon,
2012). The nephron progenitor cells (also known as cap mesen-
chyme [CM] cells) are a subset of the MM cells, which condense
around the UB tips beginning at approximately embryonic day
11.5 (E11.5) in the mouse, shortly after the UB invades the MM
and begins to branch. Under the control of signals from the UB
tips, the CM cells proliferate extensively, thereby self-renewing,
while giving rise to nephrons through a complex process that in-
cludes aggregation, epithelialization, tubular folding and elonga-
tion, segmentation, and cell differentiation (Brunskill et al., 2008;
Carroll et al., 2005; Georgas et al., 2009; Kopan et al., 2007;
Mugford et al., 2009). New nephrons are generated continuously
during kidney development, in concert with the branching of the
UB, until about postnatal day 3 (P3), when the nephron progen-
itors stop self-renewing and differentiate into a final round of
nephrons (Brunskill et al., 2011; Hartman et al., 2007; Rumballe
et al., 2011). Although the expression of several genes required
for nephrogenesis and UB branching ceases at this time (Brun-
skill et al., 2011; Hartman et al., 2007), the mechanism respon-
sible for the termination of nephrogenesis remains elusive.
The receptor tyrosine kinase RET, its ligand glial cell-line
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Figure 1. Construction and Validation of a
GdnfCreERT2 Mouse Strain
(A)b-galactosidasestainingof akidney fromanE12.5
GdnfLacZ/+ embryo after 12 hr in culture. Asterisks in
(A), (D), and (E) indicate the position of the UB.
(B) Schematic diagram of the gene-targeting strat-
egy; see Experimental Procedures for details. Note
that the DTA gene in the targeting vector is only
used for negative selection and is not present in the
targeted allele.
(C) Histogram of kidney size (maximal cross-
sectional area) in newborn wild-type mice, GdnfLacZ
(null allele) heterozygotes, and heterozygotes or
homozygotes for the GdnfCreERT2 allele. ****p <
0.0001. NS, not significant.
(D and E) YFP expression in E12.5 GdnfCreERT2/+;
R26RYFP/YFP kidneys, cultured with 10 nM 4OHT in
the medium for 16 or 40 hr, respectively, showing
YFP expression in the MM surrounding the unla-
beled UB. No YFP expression was observed in
vehicle-treated kidneys or in those lacking the
GdnfCreERT2 allele (data not shown). Scale bar,
400 mm. A time-lapse movie of a similar culture is
shown in Movie S1.family receptor alpha1 (GFRa1) play a major role in the initiation
and maintenance of UB growth and branching (Cacalano et al.,
1998; Costantini and Shakya, 2006; Enomoto et al., 1998; Moore
et al., 1996; Pichel et al., 1996; Schuchardt et al., 1994). GDNF is
secreted by MM cells that surround the UB tips (Figure 1A; Dur-
bec et al., 1996; Hellmich et al., 1996; Sa´nchez et al., 1996), RET
is expressed in the UB tip cells (Pachnis et al., 1993), and GFRa1
is expressed in both cell types (Cacalano et al., 1998; Enomoto
et al., 1998). Gdnf expression in the MM (Durbec et al., 1996;
Hellmich et al., 1996; Sa´nchez et al., 1996; Figure 1A) overlaps
with markers of the nephron progenitors, such as Six2 and
Cited1 (Sa´nchez et al., 1996), suggesting that Gdnf is expressed
by the nephron progenitors.
In this study, we report the generation of a tamoxifen-inducible
Gdnf-CreERT2 mouse line. We first used this line in cell lineage
studies, which confirmed that Gdnf is expressed by self-renew-
ing, multipotent renal progenitors that give rise to all nephron
epithelia. Next, we employed the GdnfCreERT2 allele, together
with a Rosa26 allele expressing the cytotoxic gene diphtheria
toxin A chain (DTA) in a Cre-inducible fashion, to investigate
the role of nephron progenitor cell number in determining kidney
size and nephron number. We hypothesized that the number of
progenitor cells is a limiting factor during kidney organogenesis,
and tested whether the developing kidney could still reach its
normal size and nephron number after a reduction in progenitor
cell number. Such a compensatory mechanism might involve
increased proliferation of the remaining progenitor cells and/or
prolonged nephrogenesis beyond P3, when it normally ceases.
We found that a 40% reduction in the number of fetal nephron
progenitor cells triggered a striking self-correction mechanism:
the rate of UB branching, and hence the rate at which the
nephron progenitor cells were divided between new UB tips,
was quickly reduced, allowing the number of progenitor cells
surrounding each UB tip to soon recover to its normal value.
However, the reduced rate of branching persisted, leading to
decreased overall kidney growth and nephrogenesis until birth.128 Cell Reports 7, 127–137, April 10, 2014 ª2014 The AuthorsFurthermore, nephrogenesis was not prolonged, but ceased at
the normal time, leaving a permanently compromised nephron
endowment. Hence, our studies show that the dual role of
Gdnf-expressing cells as nephron progenitors and inducers of
UB branching makes their normal numbers critical for kidney
development, as the developing kidney cannot fully compensate
for their partial depletion.
RESULTS
Gdnf-Expressing Cells Are Self-Renewing, Multipotent
Nephron Progenitors
To investigate the fate of Gdnf-expressing cells during kidney
development, we generated a mouse knockin allele in which
a tamoxifen-inducible Cre recombinase gene, CreERT2 (Feil
et al., 1997), was inserted in place of exon 2 of the Gdnf locus.
Because Gdnf knockout heterozygotes have renal hypoplasia
and homozygotes usually have renal agenesis (Moore et al.,
1996; Pichel et al., 1996; Sa´nchez et al., 1996; Treanor et al.,
1996), we included a full-length Gdnf cDNA sequence in the tar-
geting construct to prevent the generation of a Gdnf null allele
(Figure 1B). The resulting GdnfCreERT2 heterozygous mice, as
well as the homozygous animals, were viable, fertile, and had
normal-sized kidneys at birth (Figure 1C), indicating that the in-
serted Gdnf cDNA effectively substituted for the disrupted
endogenous gene.
We studied the expression pattern and induction kinetics of
the GdnfCreERT2 allele by combining it with a R26RYFP reporter
allele (Srinivas et al., 2001) and treating cultured fetal kidney ex-
plants with 4-hydroxytamoxifen (4OHT) to induce recombina-
tion. In this lineage-tracing assay, Gdnf-expressing cells are
genetically labeled by YFP expression from the constitutively ex-
pressed Rosa26 locus, so the labeling persists in all progeny
cells (Soriano, 1999; Srinivas et al., 2001). YFP reporter expres-
sion was first detected 5 hr after exposure to 4OHT (Movie S1)
and increased with time to resemble the normal expression
Figure 2. Gdnf Is Expressed by Multipotent Nephron Progenitors
with Capacity for Self Renewal
(A) Strategy for labeling Gdnf-expressing cells and their descendants.
GdnfCreERT2/+mice were crossed to R26RYFP/YFPmice and recombination was
induced by intraperitoneal injection of 2 mg tamoxifen (Tam) at E10.5. This
resulted in YFP labeling of a fraction of MM cells by E11.5 (green dots in
kidney diagram).pattern of Gdnf, with clusters of YFP+ mesenchymal cells sur-
rounding the UB tips (Figures 1D and 1E; Movie S1). We
conclude that the GdnfCreERT2 allele provides Gdnf-specific
expression of an inducible Cre recombinase without compro-
mising kidney size.
To investigate the normal fate of Gdnf-expressing kidney cells
in vivo, we induced recombination in GdnfCreERT2/+;R26RYFP/+
fetuses by administering a single dose of tamoxifen to pregnant
mice at E10.5 (Figure 2A) and analyzing the distribution of YFP+
cells at E17.5 (Figures 2B–2I). YFP+ cells were detected
throughout the kidney, in the cortex, medulla, and papilla (green
cells in Figure 2B). Labeled cells were present in the proximal and
distal nephron tubules as well as in the connecting tubules (Fig-
ure 2C), the loops of Henle (Figure 2E), and the Bowman’s
capsule and podocytes of the glomerulus (Figures 2F and 2G).
In contrast, no YFP labeling was observed in the UB-derived col-
lecting duct system (Figures 2B and 2C), the mesangial cells of
the glomeruli (Figure 2G), or the a-SMA+ or Tenascin+ medullary
and cortical stromal compartments (Figures 2H and 2I). A small
number of a-SMA, stroma-like cells within the medulla were
YFP+ (Figure 2H, arrowhead). The identity and origin of these
cells are unclear, but they might be fibroblasts (LeBleu et al.,
2013), macrophages (Duffield, 2011), or astrocytes (Sofroniew
and Vinters, 2010). Importantly, YFP+ cells were still present in
the SIX2+ CM surrounding the UB tips in the nephrogenic zone
at E17.5 (Figures 2C and 2D), even though tamoxifen-induced
recombination ceased at E11.5–E12, indicating that Gdnf-
expressing cells self-renew to maintain the nephron progenitor
population throughout fetal kidney development. Similar results
were obtained when recombination was induced at later stages
(data not shown). These data confirm that Gdnf is expressed by
the same population of self-renewing, multipotent nephron pro-
genitor cells that express Six2 and Cited1 (Boyle et al., 2008;
Kobayashi et al., 2008).
Ablation of Nephron Progenitor Cells Causes a
Reduction in Renal Growth Rate that Persists during
Fetal Development
We next used the GdnfCreERT2 allele to investigate the role of
nephron progenitor cell number in determining the kinetics of
kidney growth and the number of nephrons produced. For this
purpose, we crossed the GdnfCreERT2 mice with mice carrying
a Cre-activated Rosa26 allele encoding DTA (R26RDTA). Expres-
sion of a single DTA molecule is sufficient to induce cell death(B–I) immunofluorescence imaging of thin frozen kidney sections at E17.5, with
antibodies against renal markers in red and YFP+, Gdnf-lineage cells in green.
(B and C) Anti-Calbindin antibodies detect UB.
(D) Anti-Six2 antibodies detect nephrogenic (i.e., cap) mesenchyme (nm).
(E) Anti-Tam-Horsfall protein (THP) antibodies detect the thick ascending limb
(tal) of the loop of Henle.
(F) Anti-Podocalyxin antibodies detect glomerular podocytes (pod).
(G) Anti-Pdgfrb antibodies detect mesangial cells (mes).
(H) Anti-a-SMA antibodies detect medullary stromal cells (asterisks). SMA+
stromal cells are YFP, and labeling is observed in rare stroma-like a-SMA
cells (arrowhead).
(I) Anti-Tenascin antibodies detect cortical stromal cells (asterisks). Scale bars,
100 mm in (B), (C), (H), and (I); 50 mm in (D)–(G). bc, Bowman’s capsule;
c, cortex; ct, connecting tubule; m, medulla; p, pelvis; t, nephron tubules.
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Figure 3. Ablation of Nephron Progenitor
Cells in Early Fetal Kidneys Causes Progres-
sive Renal Hypoplasia
(A) Strategy for partial depletion of nephron pro-
genitor cells using GdnfCreERT2/+ and R26RDTA/+
mice. Blue circles represent nephron progenitors
and yellow circles represent nephron progenitors
ablatedbyDTAafter tamoxifen (Tam) administration.
(B) Kinetics of kidney growth in DTA versus control
fetuses after tamoxifen administration at E12.5.
Average size of DTA kidneys, as a percentage of
control, is indicated above the histogram for each
stage. *p = 0.0127, ****p < 0.0001. Error bars
indicate SD.
(C and D) Representative examples of control and
DTA kidneys at E19.5. a, adrenal; b, bladder; k,
kidney; t, testis.
(E and F) Hematoxylin and eosin-stained histologi-
cal sections, showing normal architecture of the
DTA kidney (F) with well-formed cortex (c), medulla
(m), and papilla (p).
(G and H) Higher-magnification images showing UB
tips (black arrowheads), CM (yellow arrowheads),
and early nephron structures (yellow dashed cir-
cles) in the nephrogenic zone of a control kidney (G)
and a hypoplastic DTA kidney (H). Scale bars,
500 mm in (E) and (F); 50 mm in (G) and (H).
See also Figures S1 and S2.through the inhibition of elongation factor 2 (Honjo et al., 1971;
Yamaizumi et al., 1978), and its effect is cell autonomous and
thus does not kill surrounding cells (Mitamura et al., 1995). In
fetuses carrying both the GdnfCreERT2 and R26RDTA alleles (for
simplicity, we refer to these as DTA fetuses), tamoxifen injection
will induce apoptosis in a fraction of the nephron progenitor cells
(Figure 3A). Based on the kinetics of expression of Rosa26 re-
porter alleles (Hayashi and McMahon, 2002; Nakamura et al.,
2006; Movie S1), we expect DTA expression and cell death to
begin 5–6 hr after tamoxifen injection and to be mostly com-
plete by 24 hr.
When tamoxifen was administered at E12.5, 1 day after UB
branching had begun, no overall growth defects were observed
in the DTA fetuses (data not shown), but they developed severe
renal hypoplasia (Figures 3B–3H). The DTA kidneys remained
normal in size at E13.5, but were significantly hypoplastic by
E14.5 and continued to grow at a reduced rate compared with
control kidneys until E19.5, when theywere only 55.7%of normal
size (Figures 3B–3D) (throughout this study, we used themaximal
cross-sectional area as the measure of kidney size). However,
theDTA kidneys retained a normal gross organization into cortex,
medulla, and papilla (Figures 3E and 3F), and the nephrogenic
zone at E19.5 appeared normal, containing newly formed neph-
rons and branching UB tips surrounded by condensed CM (Fig-
ures 3G and 3H). When tamoxifen was instead injected 2 days
later, at E14.5, similar results were observed at birth, but the renal130 Cell Reports 7, 127–137, April 10, 2014 ª2014 The Authorshypoplasia was somewhat less severe
(DTA kidneys were 69% of normal size;
Figures S1A–S1C), presumably because
the kidneys had more time to grow before
the progenitor cell ablation occurred.To ask whether kidneys could recover from a reduction in the
number of nephron progenitors at an earlier stage of kidney
development, we injected tamoxifen at E9.5. However, this re-
sulted in a more severe spectrum of renal defects, with renal
agenesis (absence of ureter and kidney) in half of the DTA fetuses
and renal hypoplasia in the other half (average 46.6% of control
size; Figures S1D–S1I). Renal agenesis is usually caused by fail-
ure of the UB to grow out from the nephric duct (Costantini,
2006), suggesting that the early ablation of a fraction of Gdnf-
expressing MM cells at E10–E10.5, before UB outgrowth,
had interfered with this critical event. In the cases in which a
small kidney developed, apparently enough Gdnf-expressing
MM cells had survived to support initial outgrowth of the UB,
but subsequent kidney growth was impaired.
Together, these data indicate that the developing fetal kid-
ney is unable to compensate for a reduction of the nephron
progenitor pool, which results in a reduced overall organ
growth rate and consequent renal hypoplasia lasting at least
until birth.
DTA Kidneys at E19.5 Have a Nephron Deficit that
Persists in Adult Animals despite Compensatory Renal
Growth
To ask how the ablation of a subset of nephron progenitor
cells affected the number of nephrons formed, we first deter-
mined the number of glomeruli per kidney at E19.5, following
Figure 4. Hypoplastic DTA Kidneys Com-
pensate in Organ Size, but Not in
Glomerular Number, during the Postnatal
Period after Tamoxifen Administration at
E12.5
(A and B) Measurement of total number of glomeruli
per kidney at E19.5 and P50.
(A) Method for counting glomeruli. Acid-digested
kidneys were transferred to a gridded plate and
glomeruli (indicated by arrowheads in inset) were
counted using a dissecting microscope.
(B) Quantification of glomeruli per kidney at
E19.5 and P50. Average glomerular number in
DTA kidneys, as a percentage of control, is
indicated above the histogram at each stage.
***p < 0.0003.
(C and D) Measurement of kidney size at P14
and P50.
(C) Images of representative control and DTA kid-
neys at P14 and P50.
(D) Quantification of the cross-sectional areas
of control and DTA kidneys at E19.5, P14, and
P50. Average DTA kidney size, as a percentage
of control, is indicated above the histogram at
each stage. E19.5 values are reproduced from
Figure 3B. ****p < 0.0001, **p = 0.0013. Error bars
indicate SD.tamoxifen administration at E12.5. Kidneyswere acid digested, a
procedure that dissolves most renal structures but spares
mature glomeruli (MacKay et al., 1987), and the glomeruli were
counted (Figure 4A). Whereas control kidneys had 1,560 ± 125
mature glomeruli, DTA kidneys had only about half as many
(753 ± 104, or 48.3% of control; Figure 4B). Thus, the renal hypo-
plasia in E19.5 DTA kidneys is accompanied by a severe deficit in
the number of mature nephrons.
Nephrogenesis normally continues until P3 (Hartman et al.,
2007; Rumballe et al., 2011) and overall kidney growth continues
for several weeks after birth. Therefore, we asked whether the
deficiencies in E19.5 DTA kidney size and/or nephron number
might be corrected during postnatal development, perhaps by
a prolonged period of nephrogenesis. We observed a progres-
sive recovery in the size of postnatal DTA kidneys, from 55.7%
of controls at E19.5 to 70.4% at P14, and to 89.3% at P50 (Fig-
ures 4C and 4D), indicating that compensatory renal growth
occurred for several weeks after birth. However, the number of
mature glomeruli per DTA kidney did not recover in the same
fashion, and at P50 it was still only 57.6% of the normal number
(6,980 ± 835 in DTA kidneys versus 12,107 ± 843 in controls; Fig-
ure 4B). Consistent with the lack of postnatal recovery in nephron
number, nephrogenesis was not prolonged in the DTA kidneys.
Both control and DTA kidneys had a similar peripheral layer of
SIX2+ CM cells at P1, which was reduced at P2-P3 and absent
by P4 (Figure 5). Therefore, a decrease in the number of nephron
progenitors during early kidney development, followed by the
normal cessation of nephrogenesis at P3, leads to a permanent
deficit in nephron numbers.A Reduction in Nephron Progenitor Cell Number Causes
a Reduced Rate of UB Branching, Allowing the Number
of Nephron Progenitors per UB Tip to Self Correct
In order to understand how the ablation of a fraction of nephron
progenitor cells resulted in renal hypoplasia and low nephron
number, we sought to measure the changes in the numbers of
these progenitor cells following the induction of DTA expression
at E12.5. One day after tamoxifen injection, the DTA kidneys
displayed numerous apoptotic cells in the nephrogenic zone,
unlike control kidneys (Figures S2A–S2D). However, the number
of apoptotic cells that are visible at any one stage does not
measure the total number of cells killed, since Cre-mediated
recombination occurs sequentially in different cells over a period
of 1 day after tamoxifen injection, and staining of fixed kidneys
provides only a snapshot of the cells that died at a single
time point. For one estimate, we examined littermates carrying
the R26RYFP allele as a proxy for the recombination of the
R26RDTA allele. Eleven percent of CM cells expressed YFP at
1 day after tamoxifen injection (Figures S2E and S2F). However,
this estimate seemed inconsistent with the degree of renal hypo-
plasia caused byDTA induction, and indeed thismethodmay not
accurately reflect the fraction of cells that express DTA, because
different Rosa26 reporter alleles may recombine with different
efficiencies (C.C., unpublished data).
Therefore, we measured the change in the number of nephron
progenitors more directly by counting the number of CM cells
surrounding individual UB tips, in DTA versus control kidneys,
at different times after tamoxifen injection (Figures 6A–6C).
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Figure 5. Renal Progenitors Are Still Present at P1 but Disappear by
P4 in Both Control and DTA Kidneys
Immunofluorescence with anti-SIX2 antibodies on thin frozen sections from
animals injected with tamoxifen at E12.5 and analyzed at P1 (A and B), P2
(C andD), P3 (E and F), and P4 (G andH). A normal nephrogenic zone is present
in control (A) and DTA littermates (B) at P1. Between P2 and P3, the SIX2+
progenitor population largely disappears in both controls (C and E) and DTA
littermates (D and F). By P4, both control and DTA kidneys have lost the SIX2+
nephron progenitor population (G and H). Asterisks indicate weakly SIX2+
renal vesicles.marker SIX2 or the UB marker calbindin1, and a z stack of
optical sections through each kidney was generated by confocal
microscopy (Figure S3). These images were used to count the
SIX2+ cells surrounding a random sample of UB tips (Figures
6A–6C), or the number of UB tips in calbindin1-stained kidneys
(Figures 6D–6F). At E13.5, 24 hr after tamoxifen injection, the
average number of SIX2+ cells surrounding each UB tip
(henceforth abbreviated as ‘‘cap size’’) in DTA kidneys was
reduced to 60% of the control value (375 versus 620 cells; Fig-
ure 6C). In contrast, the average number of UB tips per kidney
at E13.5 was indistinguishable in DTA kidneys (55 tips) versus
controls (52 tips) (Figure 6F). Thus, as expected, the first
detectable change in the DTA kidneys was a substantial reduc-
tion in the nephron progenitor population relative to control
kidneys.
While CM cells proliferate rapidly (Kobayashi et al., 2008),
some of their daughter cells leave the cap to generate nephron
epithelia, and the remaining cap is split in two with each bifurca-
tion of the UB tip (Lefevre et al., 2013). As a net result of these
processes, between E13.5 and E14.5 the average cap size in
control kidneys decreased nearly 2-fold, from 620 to 376 cells
per cap. In contrast, the average cap size in DTA kidneys barely132 Cell Reports 7, 127–137, April 10, 2014 ª2014 The Authorsdecreased at all (from 375 to 357 cells), and thus at E14.5 was
indistinguishable from the control cap size (Figure 6C). This
normalization of cap size could be explained largely by the lower
rate of UB branching observed in the DTA kidneys between
E13.5 and E14.5: whereas the UB tip number per control kidney
increased 3.6-fold, from 52 to 188, the UB tip number per DTA
kidney increased only 2.4-fold, from 55 to 133 (Figures 6D–6F).
Thus, the slower branching in DTA kidneys (a doubling of tip
number every 19 hr) split the surrounding caps in two less fre-
quently than the faster branching in control kidneys (a doubling
of tip number every 13 hr), resulting in a similar cap size in DTA
versus controls by E14.5.
To investigate themechanism by which UB branching was de-
layed in DTA kidneys between E13.5 and E14.5, we examined
the rates of apoptosis and mitosis in DTA versus control UB
tips at E14.0. There were virtually no apoptotic cells in the UB
tips of either DTA or control kidneys (Figure S4), indicating that
UB cell death did not play a significant role in the retardation of
branching. However, the percentage of phospho-histone H3+
UB tip cells was significantly lower in DTA than in control kidneys
(1.26% versus 1.87%, respectively), showing that the retarded
branching resulted, at least in part, from reduced cell prolifera-
tion (Figure S4).
We estimated the total number of SIX2+ CM cells per kidney
by multiplying the UB tip number per kidney times the average
cap size. From E13.5 to E14.5, this value increased from
32,476 to 70,556 cells in controls (2.2-fold increase) and from
20,738 to 47,445 cells in DTA kidneys (2.3-fold increase). This
suggests that the overall rate of CM cell proliferation during
this interval was similar in control and DTA kidneys. Consistent
with this prediction, measurement of phospho-histone H3+ cells
indicted that control and DTA CM cells at E13.5–E15.5 had indis-
tinguishable rates of mitosis (Figure S5).
At E15.5, the average UB tip number was further reduced in
DTA kidneys compared with controls (215 versus 364 tips; Fig-
ure 6F), indicating a continued retardation of branching between
E14.5 and E15.5 (a doubling of tip number every 35 hr in DTA kid-
neys versus 25 hr in controls). However, the average cap size in
DTA kidneys at E15.5 (263 cells) remained indistinguishable from
that in controls (253 cells; Figure 6C), suggesting that cap size
was properly regulated once it had ‘‘recovered’’ from the initial
cell ablation.
In summary, inducing apoptosis in a subset of Gdnf-express-
ing nephron progenitor cells at E12.5 led first to a large reduction
in this cell population by E13.5 and then to a reduced rate of UB
branching by E14.5. Although the number of nephron progeni-
tors per UB tip quickly returned to normal levels, revealing a
self-correction mechanism, the number of UB tips (and hence
the total number of nephron progenitor cells per kidney) re-
mained deficient, consistent with the overall renal hypoplasia
observed throughout prenatal development.
Renal Hypoplasia Caused by a Reduced Number of
Nephron Progenitor Cells Is Not Rescued by
Heterozygosity for Sprouty1, a Negative Regulator of
Receptor Tyrosine Kinase Signaling
The CM cells express both GDNF and fibroblast growth factor 10
(FGF10), two factors that work together to promote UB growth
Figure 6. A Transient Reduction of CMCells
in DTA Kidneys Is Followed by a Lasting
Retardation in UB Branching
(A–F) Tamoxifen was administered at E12.5 and
the numbers of SIX2+ CM cells per UB tip (A–C)
and UB tips per kidney (D–F) were measured 24,
48, and 72 hr later (i.e., at E13.5, E14.5, and E15.5,
respectively).
(A and B) Confocal images (optical sections) of
E13.5 kidneys labeled with anti-SIX2 antibodies,
showing the CM cells surrounding a representative
UB tip in a control (A) or mutant (B) kidney.
(C) Quantification of the numbers of SIX2+ CM
cells per UB tip. SIX2+ cells were counted in a
series of optical sections through each UB tip (see
Figure S3 and Supplemental Experimental Pro-
cedures for details). The variation in CM cell num-
ber per tip was large in both control and DTA
kidneys because the UB tips and the surrounding
mesenchyme caps vary in size depending on the
phase of the branching cycle.
(D and E) 3D rendering of branching UBs of control
and mutant kidneys at E14.5. The kidneys were
processed for whole-mount immunofluorescence with anti-Calbindin antibody and imaged using confocal microscopy and 3D rendering.
(F) Quantification of total UB tips per kidney. Error bars indicate SD. ****p < 0.0001, **p = 0.0040. NS, not significant. UB tip cell mitosis and apoptosis assays are
shown in Figure S4, and CM cell mitosis assays are shown in Figure S5.and branching (Hellmich et al., 1996; Michos et al., 2010; Ohuchi
et al., 2000).Gdnf knockout heterozygotes have small kidneys at
birth and a reduced nephron number (Benz et al., 2011; Cullen-
McEwen et al., 2001), indicating that a normal level of GDNF is
critical for normal UB branching and kidney growth. Fgf10 het-
erozygotes have normal kidneys, but Fgf10 homozygotes, as
well as embryos lacking FGF receptor 2 (Fgfr2) in the UB lineage,
have severe renal hypoplasia and reduced UB branching (Ohu-
chi et al., 2000; Zhao et al., 2004). This raised the question as
to whether the hypoplasia of DTA kidneys could be explained
simply by the reduced number of cells producing GDNF and
FGF10. The deleterious effects of Gdnf heterozygosity or Fgf10
homozygosity on kidney development can be overcome by elim-
inating one allele of Sprouty1 (Spry1), a negative regulator of
signaling downstream of the receptor tyrosine kinases (Mason
et al., 2006; Michos et al., 2010). Thus, Gdnf+/;Spry1+/ dou-
ble heterozygotes (Basson et al., 2006) and Fgf10/;Spry1+/
compound mutants (Michos et al., 2010) have normal-sized
kidneys. We therefore asked whether a reduction in Spry1
gene dosage could similarly rescue the renal hypoplasia in
DTA mice, by generating GdnfCreERT2/+;R26RDTA/+;Spry1+/ tri-
ple heterozygotes and inducing DTA expression by tamoxifen in-
jection at E12.5. We found that kidney size in the DTA fetuses at
E19.5 was only very marginally improved by Spry1 heterozygos-
ity (Figures 7A–7D), but we confirmed that, in contrast, Spry1
heterozygosity fully rescued the hypoplasia of Gdnf+/ kidneys
(Figures 7E–7H). This suggests that the cause of hypoplasia in
DTA kidneys is more complex than a simple reduction in GDNF
and FGF10 levels.
DISCUSSION
Although the process of nephrogenesis has been extensively
studied, and our understanding of the molecular and cellularmechanisms that control the formation of a nephron is growing
rapidly (Costantini and Kopan, 2010; Little and McMahon, 2012;
Mugford et al., 2009), little is known about the mechanisms that
determine the number of nephrons. This is a particularly impor-
tant issue given the evidence that low nephron number is a risk
factor for hypertension and chronic kidney disease (Benz et al.,
2011; Hoy et al., 2006; Keller et al., 2003; Luyckx and Brenner,
2005; Schreuder, 2012). In this study, we first confirmed that
Gdnf is expressed by the multipotent, self-renewing nephron
progenitor cells during kidney development. We then asked
whether ablating a fraction of these nephron progenitor cells
early in kidney development would limit the overall growth of
the organ and the number of nephrons formed, or whether reg-
ulatory mechanisms exist that would allow the developing kid-
ney to recover from a deficit in the number of these progenitors.
Mutations in several genes expressed in the nephron progeni-
tors have established that genetic defects in this cell population
can compromise nephron endowment (Cain et al., 2010); how-
ever, our approach is distinct in that it reduces the number of
progenitor cells without genetically altering the surviving cells.
We found that during fetal development, the kidney cannot
recover from a reduction in nephron progenitor cells, leading
to renal hypoplasia and low nephron number at birth. After birth,
although the overall size of such kidneys recovers extensively
via compensatory growth, nephrogenesis ceases at the normal
time, P3, and hence the number of nephrons remains perma-
nently reduced in the adult mice. Thus, the number of fetal
nephron progenitor cells is an important determinant of nephron
number.
Although the importance of reciprocal signaling between the
UB and surrounding CM has long been appreciated (Grobstein,
1956; Saxe´n, 1987), our studies provide a remarkable example of
automatic error correction in the size of the nephron progenitor
cap, mediated by these reciprocal interactions. The first visibleCell Reports 7, 127–137, April 10, 2014 ª2014 The Authors 133
Figure 7. Unlike the Hypoplasia of Gdnf+/
Kidneys, the Hypoplasia of DTA Kidneys
Cannot Be Rescued by Removing One
Sprouty1 Allele
(A–C) Representative kidneys of control, DTA, and
DTA;Spry1+/ fetuses at E19.5. Tamoxifen (2 mg)
was administered at E12.5.
(D) Quantification of the sizes of control, DTA, and
DTA;Spry1+/ kidneys.
(E–G) Representative kidneys of control, Gdnf+/,
and Gdnf+/;Spry1+/ fetuses at E19.5.
(H) Quantification of the sizes of control, Gdnf+/,
and Gdnf+/;Spry1+/ kidneys. ****p < 0.0001,
***p < 0.001, NS, not significant. a, adrenal;
b, bladder; k, kidney. Error bars indicate SD.consequence, 24 hr after injection of tamoxifen at E12.5 to
induce the expression of DTA in Gdnf-expressing cells, was a
40% reduction, compared with controls, in the number of CM
cells surrounding the average UB tip (the ‘‘cap size’’). This was
followed (24–48 hr after tamoxifen injection) by a reduction in
the rate of UB tip cell proliferation and UB branching, which
was apparently a secondary effect of the reduced cap size. Inter-
estingly, by 48 hr after tamoxifen injection, the average cap size
in DTA kidneys had normalized. However, there was no detect-
able increase in the rate of mitosis of the surviving nephron
progenitor cells in response to the ablation of many of their
‘‘neighbors’’; instead, the normalization of cap size in DTA kid-
neys appeared to be due primarily to a reduced rate of UB
branching, which caused the surrounding cap to be split less
frequently than in control kidneys. Whereas the UB branching
rate remained abnormally low between 48 and 72 hr after tamox-
ifen injection, the cap size remained normal during this interval.
These results suggest that the size of the nephron progenitor
cap surrounding each UB tip is regulated by a sensitive self-
correction mechanism mediated by reciprocal interactions be-
tween the cap cells and UB tip cells. A decrease in cap cell
number results in a lower level of signaling to the UB tip cells.
This causes a reduced rate of UB branching, which in turn allows
the cap size to recover without any increase in cap cell prolifer-
ation. However, the total number of nephron progenitor cells per
kidney remained low due to the reduced number of UB tips, and
the size of theUB tree and overall growth of the fetal kidney, once
retarded, did not recover.
The retardation of UB branching in response to a reduced CM
cell number presumably reflects the roles of growth factors pro-
duced by the CM cells, including GDNF, FGF10, and others
(Costantini, 2012; Durbec et al., 1996; Hellmich et al., 1996; Ish-
ibe et al., 2009; Ohuchi et al., 2000; Sa´nchez et al., 1996; Vega
et al., 1996): if fewer CM cells are present, fewer of these UB-
stimulatory factors will be produced. However, we obtained134 Cell Reports 7, 127–137, April 10, 2014 ª2014 The Authorsgenetic evidence that the reduced growth
rate of DTA kidneys was not due simply to
reduced growth factor signaling via re-
ceptor tyrosine kinases, such as Ret or
FGF receptors. Although heterozygosity
for Sprouty1, a negative regulator of re-
ceptor tyrosine kinase signaling, fullyrescues the renal hypoplasia caused by Gdnf heterozygosity or
Fgf10 homozygosity (Mason et al., 2006; Michos et al., 2010),
it failed to rescue the hypoplasia of DTA kidneys. This suggests
that additional functions of the nephron progenitor cells, such as
the expression of other classes of growth factors for the UB, as
well as the formation of nephron epithelia, are abrogated by their
ablation, contributing to the reduced UB branching and the re-
sulting renal hypoplasia at birth. Although we cannot formally
exclude the possibility that ablating the progenitors of a small
number of medullary stromal cells (Figure 2H) contributes to
the renal hypoplasia and nephron deficit in DTA fetuses, this
seems very unlikely given the rarity of these cells.
It is interesting to compare our results regarding nephron pro-
genitor cell ablation with similar results from other developing
organs. Stanger et al. (2007) used inducible DTA ablation to
reduce progenitor cell number in the mouse pancreas and liver,
and revealed that these two organs use different mechanisms to
control their final size. Ablating a fraction of Pdx1-expressing
pancreatic progenitor cells (which give rise to all the epithelial
lineages of the pancreas, and thus to a large fraction of total
pancreatic cells) caused a substantial and permanent reduction
in pancreas size, indicating that the final pancreas size is limited
by the number of progenitor cells early in development. In
contrast, the liver was able to regulate its size rapidly and pre-
cisely after a major reduction in the number of LAP-expressing
early hepatic progenitor cells, consistent with the regenerative
ability of the adult liver (Stanger et al., 2007). The kidney showed
a more complex response to ablation of a fraction of nephron
progenitors, with similarities to both the liver and the pancreas.
In terms of total organ size, whereas the kidney remained
hypoplastic during fetal development, the organ was able to
regulate its size during postnatal development; however, this
apparently occurred by compensatory growth, not by prolonged
or increased postnatal nephrogenesis. Compensatory renal
growth, in which the remaining nephrons increase in size, is a
well-established consequence of the increased blood flow when
nephron number is compromised by injury or resection (Hoy
et al., 2006). Considering nephron number, the behavior after
ablation was much like that observed in the pancreas, as the
number of nephrons was permanently reduced approximately
in proportion to the initial reduction of progenitor cells.
Our results provide important insights that should help to
distinguish between several potential models for the control of
nephron number. They argue against the existence of a
‘‘nephron counting’’ mechanism in which the number of neph-
rons during development is sensed, and nephrogenesis is accel-
erated or prolonged until the appropriate number is achieved.
The lack of such a mechanism is also consistent with the wide
natural variation in nephron number in humans, although one
study in sheep suggested that nephrogenesis can be prolonged
in utero beyond its normal termination, after unilateral nephrec-
tomy in the fetus (Douglas-Denton et al., 2002). Our results rule
out a progenitor-cell counting mechanism, which would monitor
the total number of these cells per kidney and adjust their prolif-
eration to maintain the appropriate number (but they do support
a mechanism that maintains the number of nephron progenitor
cells per UB tip, as discussed above). Instead, our findings sug-
gest that the number of nephron progenitor cells in the fetal kid-
ney is critical, initially, because these cells produce factors that
promote UB growth and branching. When their numbers are
experimentally reduced, there is a lasting reduction in the rate
of branching and hence in the rate of nephron formation. Why
does the DTA kidney stop forming new nephrons at the normal
time (P3), leaving it with a permanent nephron deficit? One
possibility consistent with our data is a ‘‘cell-division counting
mechanism’’ in which the progenitor cells can divide only a fixed
number of times, as has been proposed for glial precursor cells
as well as the Pdx1+ pancreatic progenitors (Gu et al., 2002;
Stanger et al., 2007). According to such a model, nephrogenesis
will proceed until the progenitor cells have expended their limited
proliferative capacity, and thus fewer progenitors will result in
fewer nephrons by the time they stop dividing. However, it
seemsmore likely that nephron progenitor self-renewal is limited
by UB-derived signals and hence by UB tip number. A different
model also consistent with our data is a ‘‘timing mechanism,’’
either intrinsic or extrinsic to the kidney, that eliminates the
nephron progenitor pool at P3 regardless of the progress of
nephrogenesis at that time (Brunskill et al., 2011; Hartman
et al., 2007; Hendry et al., 2011). Further studies will be needed
to distinguish between these (or other potential) models.
The DTA mouse should be a useful model in which to test the
relationship between low nephron endowment and the develop-
ment of hypertension and renal disease. Although epidemiolog-
ical studies in humans, and experiments with some animal
models, suggest such a connection, a direct cause-and-effect
relationship has not been established (Moritz et al., 2009). There
are many mouse mutants with renal hypoplasia and reduced
nephron number; however, many of these mutations also cause
renal dysplasia (i.e., tissue malformation) or affect other organs
besides the kidney (Cain et al., 2010). Other animal studies
have used prenatal insults, such as a low-protein diet, to cause
low birth weight and low nephron endowment (Moritz et al.,
2009), but such treatments likely affect the development of otherorgans. An advantage of the DTAmouse is that it is generated by
the transient ablation of nephron progenitor cells during fetal
development, and none of the genes required for normal kidney
development have been knocked out. Thus, any abnormalities in
blood pressure could be attributed more directly to changes in
nephron number. Furthermore, it should be possible to vary
the severity of the nephron deficit by varying the timing or
dose of tamoxifen administration, or the gene dosage of the
GdnfCreERT2 and R26RDTA alleles.
EXPERIMENTAL PROCEDURES
Mouse Strains
A GdnfCreERT2 targeting vector (Figure 1B) was generated using 4.2 kb 50 and
4.1 kb 30 fragments of the mouse Gdnf gene. A mouse Gdnf cDNA and then
IRES2, CreERT2, SV40 polyA, and Pgk/neo were inserted in frame into exon
2 of the mouse locus. The DTA gene was used for negative selection. Linear-
ized targeting vector was electroporated into CSL3 embryonic stem cells
(ESCs, a gift from Dr. C.S. Lin, Columbia University) and clones selected
with G418. Targeted clones were identified by Southern blot using an external
probe (not shown). Littermates of DTA mice (wild-type, R26DTA/+, or
GdnfCreERT2/+) showed no defects in kidney size or anatomy, and were all
used as controls. See Supplemental Experimental Procedures for details on
the mouse strains used.
Mouse Manipulations
Animal experiments followed NIH guidelines and were approved by the Insti-
tutional Animal Care and Use Committee of Columbia University. Tamoxifen
(2 mg, T5648; Sigma) or vehicle (sunflower oil) was administered by intraperi-
toneal injection at noon. We observed a high frequency of miscarriage in the
tamoxifen-treated dams. Hence, to generate juvenile and adult DTA mice, if
tamoxifen-treated dams had not delivered by late afternoon on E19.5, the
pups were delivered by cesarean section and transferred to a lactating foster
mother.
Kidney Culture
Kidneys were dissected from E12.5 embryos and cultured on Transwell filters
(Costantini et al., 2011). For b-galactosidase detection, kidneys were pro-
cessed as previously described (Burn, 2012). For tamoxifen-induced recombi-
nation in culture, 4-OH-tamoxifen (H7904; Sigma) or vehicle (ethanol) was
added to the culture media and recombination-induced fluorescence was de-
tected by time-lapse imaging (Costantini et al., 2011).
Imaging and Data Analysis
Kidney cross-sectional areas, UB tip numbers, and proliferating cells were
quantified manually using ImageJ. SIX2+ CM cells and UB tip cells (stained
with Hoechst 33342) were counted using the Image-based Tool for Counting
Nuclei plugin for ImageJ (Byun et al., 2006) on confocal z stacks. This method
of nuclear counting, when applied to a z stack, is biased by overprojection.
This bias was corrected by using the formula N = (z 3 n)/(z + D) (Marrable,
1962), where N is the total number of SIX2+ nuclei per cap, n is the crude count
of SIX2+ nuclei in all z sections of a given cap, D is the nuclei diameter, and z is
the distance between sections. Data were analyzed by Student’s t test.
Doubling time for UB tips was calculated as (t2 – t1 / log2 [number of tips
at t2 / number of tips at t1]), where t is time.
Counting Glomeruli
HCl maceration of whole kidneys was performed according to MacKay et al.
(1987). Briefly, isolated and decapsulated kidneys were roughly chopped
with a razor blade and incubated in 6N HCl at 37C. Newborn kidneys were
incubated in 1 ml for 30 min, 2-week-old kidneys were incubated in 2.5 ml
for 60 min, and adult kidneys were incubated in 5 ml for 90 min. Pipetting up
and down after maceration further disrupted the kidneys. Five volumes of
distilled water were added to the samples, followed by incubation at 4C over-
night. Then, 1 ml of macerate was pipetted into a cell culture dish with a 2 mmCell Reports 7, 127–137, April 10, 2014 ª2014 The Authors 135
grid (Nalge Nunc Int 174926) and glomeruli were counted in a 112 mm2 area.
The experimenter was blind to the genotypes of the kidneys being scored.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one movie and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.02.033.
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